Design: A total of 95 equivocal (72) and positive (23) cases by HercepTest (Dako) were tested with Pathway Her2/4B5 (Ventana) and Pathvysion Her2 fluorescence ISH (FISH; Abbott). All interpretations for IHC and FISH were done according to the 2013 ASCO/CAP guidelines. Three pathologists scored the Her2 IHC independently. Consensus opinion was used to resolve cases in which the pathologists disagreed on the IHC score. Results: Of the 95 cases tested with 4B5, 55% were negative, 26% equivocal, and 19% positive. Fifty-two (72%) of the equivocal cases with HercepTest were interpreted as negative with 4B5. Of the 72 equivocal HercepTest results, 71% (51) were non-amplified, 12% (9) equivocal and 17% (12) amplified by FISH. Of the 25 equivocal results with 4B5, 36% (9) were non-amplified, 20% (5) equivocal and 44% (11) amplified by FISH. Of the 23 positive results with HercepTest, 9% (2) were non-amplified by FISH and one (4%) was equivocal. All of the positive cases by 4B5 were amplified by FISH. Three Her2-negative IHC cases by 4B5 were amplified by FISH (two had monosomy 17 and one polysomy 17). By cost analysis, testing of equivocal IHC cases with FISH amounted to $14,590 for HercepTest and $5,066 for 4B5.
Introduction:
Adenovirus infection in patients who have undergone hematopoietic stem cell transplant (HSCT) is associated with significant morbidity related to respiratory, genitourinary, and gastrointestinal (GI) involvement, as well as disseminated disease and death. HSCT patients with GI symptoms often have endoscopy with GI biopsies for evaluation. The differential diagnosis in these specimens includes graft-vs-host disease (GVHD), infection, and medication-related changes. As these entities may have overlapping histologic features, and cytopathic changes with adenovirus are often subtle, immunohistochemistry (IHC) should be considered as part of the surgical pathologic evaluation. Detection of adenovirus is critically important in the HSCT population as infection may be fatal and can be treated using agents such as cidofovir. Methods: GI specimens with adenovirus IHC performed from adult and pediatric HSCT patients from 2015 to 2016 at a single institution were reviewed to identify the frequency and pattern of positive cases. Results were compared with H&E-stained sections, concurrent studies for adenovirus, and clinical history. Results: Four specimens (3.4%) with positive adenovirus IHC were identified from 117 GI cases for which adenovirus IHC was performed over the two-year period. Two specimens were from the duodenum and two from the colon. All cases had concurrent GVHD. Three cases had positive adenovirus PCR; of these, one also had positive adenovirus shell vial culture. The fourth case had positive stool adenovirus enzyme immunoassay and was also positive for adenovirus by viral culture of the GI specimens. Review of H&E-stained sections in IHC-positive areas of these four cases identified subtle viral cytopathic changes such as enlarged or smooth nuclei. Conclusions: Adenovirus-infected cells can be rare and may show no or subtle viral cytopathic changes by standard H&E-stained preparation of GI biopsies. In HSCT patients, a low threshold for ordering immunohistochemical stains for adenovirus is warranted due to the clinical importance of this infection.
Low Tumor Stroma Ratio Is a Poor Prognostic Indicator in Urothelial Cancer
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Introduction: Bladder cancer is the second most common malignancy of genitourinary tract in India. There is a need of prognostic markers to identify patients who are most likely to show recurrence and therefore can be kept on close follow up. Tumor Stroma Ratio (TSR) has recently been discovered to be either good or bad prognostic indicator in various carcinomas. The present study evaluates the role of TSR in urothelial cancer. Method: H&E stained sections of urothelial cancer (n = 100) were scanned with a digital slide scanning microscope (Carl Zeiss Microscopy GmbH, Germany) at 20x magnification using Metafer software (MetaSystems Hard & Software GmbH, Germany). The images of different fields were stitched together by VSlide software (MetaSystems Hard & Software GmbH, Germany) to get composite picture of whole slide. A randomized computer generated list was used for selection of 10 images from each case. Using ImageJ software, tumor area and stromal area were measured separately, added for 10 images and then TSR was calculated in each case. Results: The study included 63% low grade (mean TSR, 0.77 ± 0.1) and 37% high grade tumors (mean TSR, 0.70 ± 0.2). Among them 86 were non-muscle invasive cases (mean TSR, 0.77 ± 0.1) and 14 were muscle invasive cases (mean TSR, 0.62 ± 0.2). Only two cases of low grade tumors (3.2%) and six of 37 high grade cases
